Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse

scientific article

Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2003PNAS..100.7283B
P356DOI10.1073/PNAS.1237725100
P8608Fatcat IDrelease_d3ujb36uxfdtfon56amimnj3iq
P932PMC publication ID165867
P698PubMed publication ID12771386
P5875ResearchGate publication ID10739846

P50authorNancy AndrewsQ4793337
Michael H. PicardQ37386535
Michael SimonsQ39375925
P2093author name stringMonty Krieger
Mark J Post
Anne Braun
Helena E Miettinen
Eliza Vasile
Danita M Yoerger
Joshua L Krieger
Shamsah Ebrahim
Songwen Zhang
Teresa M Holm
P2860cites workHigh density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent mannerQ24292170
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolismQ24646308
Method for non-invasively recording electrocardiograms in conscious miceQ24801627
Inflammation in acute coronary syndromesQ28193283
Identification of scavenger receptor SR-BI as a high density lipoprotein receptorQ28273182
Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systemsQ28354246
Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient miceQ28365792
Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bileQ28507887
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivoQ28511213
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein EQ29615236
Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient miceQ31961261
Apolipoprotein E: a cholesterol transport protein with lipid transport-independent cell signaling propertiesQ32068720
Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivoQ32085481
Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipaseQ33604083
Dyslipoproteinaemia of liver diseaseQ33688775
Probucol suppresses ICAM-1 expression in rat mesangial cells: possible role of IL-1.Q33690971
Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.Q33953583
Apolipoprotein E and atherosclerosisQ33959445
Adriamycin-induced heart failure: mechanism and modulationQ33963576
ProbucolQ34107317
Oxidants and antioxidants in atherosclerosisQ34338340
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemiaQ34340579
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosQ34360883
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiologyQ35603368
Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorptionQ36288943
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic miceQ36385620
Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonadQ37348207
Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient miceQ37368611
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthaseQ38299352
Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemiaQ38672462
Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits.Q41700988
Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl etherQ42259584
Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient miceQ42537447
Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cellsQ43681941
Anti-atherogenic antioxidants regulate the expression and function of proteasome alpha-type subunits in human endothelial cellsQ43726517
Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient miceQ43729308
Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transferQ43805131
Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).Q43890114
Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI.Q43893087
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient miceQ43893171
The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for efQ43908322
Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits.Q43912985
Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat.Q44009245
Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammationQ44064973
Probucol increases the selective uptake of HDL cholesterol esters by Hep G2 human hepatoma cellsQ44308720
Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levelsQ45881945
Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.Q45998910
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient miceQ46141600
Echocardiographic determination of risk area size in a murine model of myocardial ischemiaQ47257697
Familial lecithin:cholesterol acyltransferase deficiency--a clinical survey.Q54135509
Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer proteinQ62383302
Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosisQ68095783
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progressionQ72690003
Effects of dietary fat levels on the absorption and tissue accumulation of probucol in the ratQ72871646
Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptorQ72992440
Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouseQ73295343
Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study GroupQ73552611
Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol effluxQ73596081
Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient miceQ74152611
Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levelsQ74471880
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectheart diseaseQ190805
coronary artery diseaseQ844935
knockout mouseQ1364740
P304page(s)7283-7288
P577publication date2003-05-27
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleProbucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse
P478volume100

Reverse relations

cites work (P2860)
Q37211062"Who's on first": determining the roster for the key players in the reverse cholesterol transport pathway
Q449892375th Annual International Conference on HDL Cholesterol: metabolic pathways and drug developments
Q37109628Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds
Q36843340ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis
Q58737823Attenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in mice
Q33435708Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease
Q34948139Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis
Q27313306Dietary manipulation and social isolation alter disease progression in a murine model of coronary heart disease
Q99567286Differential roles of Scavenger receptor class B type I: A protective molecule and a facilitator of atherosclerosis (Review)
Q55339140Effect of probucol on hemodynamics, rheology and blood lipid of diabetic retinopathy.
Q57113067Effects of mulberry leaf on experimental hyperlipidemia rats induced by high-fat diet
Q34581244Excess cholesterol induces mouse egg activation and may cause female infertility.
Q28390580Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model
Q30528268Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice.
Q34998020Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport
Q38293430HDL biogenesis, remodeling, and catabolism.
Q36765386HDL signaling and protection against coronary artery atherosclerosis in mice
Q36232365Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation
Q37584875High-density lipoprotein metabolism and the human embryo.
Q57817035Hyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice
Q37240487Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease
Q27664175In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1
Q36708971Influence of PDZK1 on lipoprotein metabolism and atherosclerosis
Q36625645Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice
Q30942732Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice
Q57349944Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improvein vitrodissolution andin vivooral absorption
Q34726050Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI
Q34657849Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ domains of PDZK1.
Q36628814Oral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomes
Q36808468Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization
Q35880331Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport
Q37382165Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis
Q37151611Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice
Q45275694Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate.
Q37108304Progression and disruption of advanced atherosclerotic plaques in murine models
Q57123755Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins
Q64237412Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability
Q36406570Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
Q33767978Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI
Q47377607Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering
Q34965254SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction
Q36227219SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance
Q39161542SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis
Q37639147Scavenger Receptor Class B Type 1 Deletion Led to Coronary Atherosclerosis and Ischemic Heart Disease in Low-density Lipoprotein Receptor Knockout Mice on Modified Western-type Diet
Q33567588Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsis
Q35215415Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia
Q92051453Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation
Q51804653Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI.
Q53571308Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI.
Q51600809Supercritical fluid chromatography with tandem mass spectrometry combined with postcolumn compensation and one-step acetone protein precipitation to evaluate the bioavailability of probucol solid dispersion tablet.
Q33937822Susceptibility gene for stroke or cerebral infarction in the Han population in Hunan Province of China
Q28208721Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism
Q35952837Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors
Q37981725Therapeutic strategies to deplete macrophages in atherosclerotic plaques
Q33379402Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice
Q64990442Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice.